Publications by authors named "Pius Waldmeier"

Claim this Profile
6
6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compounds.
Stephan Röver, Mirjana Andjelkovic, Agnès Bénardeau, Evelyne Chaput, Wolfgang Guba, Pius Waldmeier

J Med Chem· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.
Henner Knust, Guido Achermann, Theresa Ballard, Bernd Buettelmann, Rodolfo Gasser, Pius Waldmeier

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.
Leo Alig, Jochem Alsenz, Mirjana Andjelkovic, Stefanie Bendels, Agnès Bénardeau, Pius Waldmeier

J Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient synthesis of novel NK1 receptor antagonists: selective 1,4-addition of grignard reagents to 6-chloronicotinic acid derivatives.
Fabienne Hoffmann-Emery, Hans Hilpert, Michelangelo Scalone, Pius Waldmeier

J Org Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis